VentiRx Pharmaceuticals Company
.jpg)
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
Estimated Revenue:
$1M to $10M
Headquarters:
Seattle, Washington, United States
Industry:
Women Cancer Treatment